Endoplasmic reticulum stress and bipolar disorder - Almost forgotten therapeutic drug targets in the unfolded protein response pathway revisited

CNS and Neurological Disorders - Drug Targets

Volumn 15, Issue 4, 2016, Pages 403-413

  Bengesser, Susanne A ^a   Fuchs, Robert ^a   Lackner, Nina ^a   Birner, Armin ^a   Reininghaus, Bernd ^a   Meier Allard, Nathalie ^a   Stracke, Anika ^a   Kapfhammer, Hans Peter ^a   Reininghaus, Eva Z ^a   Wallner Liebmann, Sandra ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Bipolar disorder; Endoplasmic reticulum; Endoplasmic reticulum stress; Lithium; Unfolded protein response; Valproate

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; CALCIUM CHANNEL L TYPE; CALCIUM ION; CHAPERONE; CYCLIC AMP BINDING PROTEIN; GLUCOSE REGULATED PROTEIN 78; GLUCOSE REGULATED PROTEIN 94; GLYCOGEN SYNTHASE KINASE 3BETA; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HEAT SHOCK PROTEIN 70; HISTONE DEACETYLASE 1; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; OLANZAPINE; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN C; STRESS ACTIVATED PROTEIN KINASE; TUNICAMYCIN; VALPROIC ACID; X BOX BINDING PROTEIN 1; TRANQUILIZER;

ARTICLE; BIPOLAR DISORDER; ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION; ENDOPLASMIC RETICULUM STRESS; GENETIC ASSOCIATION; GLIOMA CELL; OBESITY; OXIDATIVE STRESS; SUICIDE ATTEMPT; UNFOLDED PROTEIN RESPONSE; WOLFRAM SYNDROME; DRUG EFFECT; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN UNFOLDING; SIGNAL TRANSDUCTION;

ANTIMANIC AGENTS; BIPOLAR DISORDER; ENDOPLASMIC RETICULUM STRESS; HUMANS; PROTEIN UNFOLDING; SIGNAL TRANSDUCTION;

EID: 84964048198     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/1871527315666160321104613     Document Type: Article

References (116)

1. Hauser M, Galling B, Correll CU. Suicidal ideation and suicide attempts in children and adolescents with bipolar disorder: a systematic review of prevalence and incidence rates, correlates, and targeted interventions. Bipolar Disord 2013; 15(5): 507-23.
2. Rothenhausler HB. Kompendium Praktische Psychiatrie. Springer, 2007.
3. Bengesser S, Reininghaus E. Genetics of Bipolar Disorder. Peter-Lang, 2013.
4. Benazzi F, Akiskal HS. Biphasic course in bipolar II outpatients: prevalence and clinical correlates of a cyclic pattern described by Baillarger and Falret in hospitalised patients in 1854. J Affect Disord 2006; 96(3): 183-7.
5. Dilling H F Freyberger HJ. Taschenfuhrer zur ICD-10-Klassifikation psychischer Storungen. Huber, Bern, 2010.
6. Abdolmaleky HM, Yaqubi S, Papageorgis P, et al. Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder. Schizophr Res 2011; 129(2-3): 183-90.
7. Ghadirivasfi M, Nohesara S, Ahmadkhaniha HR, et al. Hypomethylation of the serotonin receptor type-2A Gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2011; 156(5): 536-45.
8. Nohesara S, Ghadirivasfi M, Mostafavi S, et al. DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder. J Psychiatr Res 2011; 45(11): 1432-8.
9. Abdolmaleky HM, Cheng KH, Faraone SV, et al. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet 2006; 15(21): 3132-45.
10. Abdolmaleky HM, Cheng KH, Russo A, et al. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 2005; 134B(1): 60-6.
11. Abdolmaleky HM, Smith CL, Faraone SV, et al. Methylomics in psychiatry: Modulation of gene-environment interactions may be through DNA methylation. Am J Med Genet B Neuropsychiatr Genet 2004; 127B(1): 51-9.
12. Kakiuchi C, Ishiwata M, Nanko S, et al. Association analysis of HSP90B1 with bipolar disorder. J Hum Genet 2007; 52(10): 794-803.
13. Kakiuchi C, Iwamoto K, Ishiwata M, et al. Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nat Genet 2003; 35(2): 171-5.
14. Wang JF, Bown C, Young LT. Differential display PCR reveals novel targets for the mood-stabilizing drug valproate including the molecular chaperone GRP78. Mol Pharmacol 1999; 55(3): 521-7.
15. Zhang K, Kaufman RJ. From endoplasmic-reticulum stress to the inflammatory response. Nature 2008; 454(7203): 455-62.
16. Volk T, Hensel M, Kox WJ. Transient Ca2+ changes in endothelial cells induced by low doses of reactive oxygen species: role of hydrogen peroxide. Mol Cell Biochem 1997; 171(1-2): 11-21.
17. Gregersen N, Bross P. Protein misfolding and cellular stress: an overview. Methods Mol Biol 2010; 648: 3-23.
18. Schubert U, Anton LC, Gibbs J, Norbury CC, Yewdell JW, Bennink JR. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 2000; 404(6779): 770-4.
19. Han F, Yan S, Shi Y. Single-prolonged stress induces endoplasmic reticulum-dependent apoptosis in the hippocampus in a rat model of post-traumatic stress disorder. PLoS One 2013; 8(7): e69340.
20. Li S, Yang L, Selzer ME, Hu Y. Neuronal endoplasmic reticulum stress in axon injury and neurodegeneration. Ann Neurol 2013; 74(6): 768-777.
21. Lakshmanan AP, Harima M, Suzuki K, et al. The hyperglycemia stimulated myocardial endoplasmic reticulum (ER) stress contributes to diabetic cardiomyopathy in the transgenic non-obese type 2 diabetic rats: a differential role of unfolded protein response (UPR) signaling proteins. Int J Biochem Cell Biol 2013; 45(2): 438-47.
22. Sage AT, Holtby-Ottenhof S, Shi Y, Damjanovic S, Sharma AM, Werstuck GH. Metabolic syndrome and acute hyperglycemia are associated with endoplasmic reticulum stress in human mononuclear cells. Obesity 2012; 20(4): 748-55.
23. Nomura Y. Pharmacological studies on neurodegenerative diseases focusing on refolding and degradation of unfolded proteins in the endoplasmic reticulum. Yakugaku Zasshi 2014; 134(4): 537-43.
24. Omura T, Kaneko M, Okuma Y, Matsubara K, Nomura Y. Endoplasmic reticulum stress and Parkinson’s disease: the role of HRD1 in averting apoptosis in neurodegenerative disease. Oxid Med Cell Longev 2013; 2013: 239854.
25. Valdes P, Mercado G, Vidal RL, et al. Control of dopaminergic neuron survival by the unfolded protein response transcription factor XBP1. Proc Natl Acad Sci USA 2014; 111(18): 6804-9.
26. Hetz C, Mollereau B. Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat Rev Neurosci 2014; 15(4): 233-49.
27. Roussel BD, Kruppa AJ, Miranda E, Crowther DC, Lomas DA, Marciniak SJ. Endoplasmic reticulum dysfunction in neurological disease. Lancet Neurol 2013; 12(1): 105-18.
28. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007; 8(7): 519-29.
29. van Schadewijk A, van’t Wout EF, Stolk J, Hiemstra PS. A quantitative method for detection of spliced X-box binding protein-1 (XBP1) mRNA as a measure of endoplasmic reticulum (ER) stress. Cell Stress Chaperones 2012; 17(2): 275-9.
30. Pfaffenseller B, Wollenhaupt-Aguiar B, Fries GR, et al. Impaired endoplasmic reticulum stress response in bipolar disorder: cellular evidence of illness progression. Int J Neuropsychopharmacol 2014; 17(9): 1453-63.
31. Hayashi A, Kasahara T, Kametani M, Toyota T, Yoshikawa T, Kato T. Aberrant endoplasmic reticulum stress response in lymphoblastoid cells from patients with bipolar disorder. Int J Neuropsychopharmacol 2009; 12(1): 33-43.
32. So J, Warsh JJ, Li PP. Impaired endoplasmic reticulum stress response in B-lymphoblasts from patients with bipolar-I disorder. Biol Psychiatry 2007; 62(2): 141-7.
33. Bown CD, Wang JF, Chen B, Young LT. Regulation of ER stress proteins by valproate: therapeutic implications. Bipolar Disord 2002; 4(2): 145-51.
34. Bown C, Wang JF, MacQueen G, Young LT. Increased temporal cortex ER stress proteins in depressed subjects who died by suicide. Neuropsychopharmacology 2000; 22(3): 327-32.
35. Bown CD, Wang JF, Young LT. Increased expression of endoplasmic reticulum stress proteins following chronic valproate treatment of rat C6 glioma cells. Neuropharmacology 2000; 39(11): 2162-9.
36. Chen B, Wang JF, Young LT. Chronic valproate treatment increases expression of endoplasmic reticulum stress proteins in the rat cerebral cortex and hippocampus. Biol Psychiatry 2000; 48(7): 658-64.
37. Kakiuchi C, Ishigaki S, Oslowski CM, Fonseca SG, Kato T, Urano F. Valproate, a mood stabilizer, induces WFS1 expression and modulates its interaction with ER stress protein GRP94. PLoS One 2009; 4(1): e4134.
38. Shao L, Sun X, Xu L, Young LT, Wang JF. Mood stabilizing drug lithium increases expression of endoplasmic reticulum stress proteins in primary cultured rat cerebral cortical cells. Life Sci 2006; 78(12): 1317-23.
39. Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 2001; 276(39): 36734-41.
40. Baumeister P, Dong D, Fu Y, Lee AS. Transcriptional induction of GRP78/BiP by histone deacetylase inhibitors and resistance to histone deacetylase inhibitor-induced apoptosis. Mol Cancer Ther 2009; 8(5): 1086-94.
41. Wu S, Zheng SD, Huang HL, et al. Lithium down-regulates histone deacetylase 1 (HDAC1) and induces degradation of mutant huntingtin. J Biol Chem 2013; 288(49): 35500-10.
42. Hiroi T, Wei H, Hough C, Leeds P, Chuang DM. Protracted lithium treatment protects against the ER stress elicited by thapsigargin in rat PC12 cells: roles of intracellular calcium, GRP78 and Bcl-2. Pharmacogenom J 2005; 5(2): 102-11.
43. Kim AJ, Shi Y, Austin RC, Werstuck GH. Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3. J Cell Sci 2005; 118(Pt 1): 89-99.
44. Freland L, Beaulieu JM. Inhibition of GSK3 by lithium, from single molecules to signaling networks. Front Mol Neurosci 2012; 5: 14.
45. O’Brien WT, Klein PS. Validating GSK3 as an in vivo target of lithium action. Biochem Soc Trans 2009; 37(Pt 5): 1133-8.
46. Hampp G, Albrecht U. The circadian clock and mood-related behavior. Commun Integr Biol 2008; 1(1): 1-3.
47. Hampp G, Ripperger JA, Houben T, et al. Regulation of monoamine oxidase A by circadian-clock components implies clock influence on mood. Curr Biol 2008; 18(9): 678-83.
48. Schmutz I, Chavan R, Ripperger JA, et al. A specific role for the REV-ERBalpha-controlled L-Type Voltage-Gated Calcium Channel CaV1.2 in resetting the circadian clock in the late night. J Biol Rhythms 2014; 29(4): 288-98.
49. Hiroi T, Wei H, Hough C, Leeds P, Chuang DM. Protracted lithium treatment protects against the ER stress elicited by thapsigargin in rat PC12 cells: roles of intracellular calcium, GRP78 and Bcl-2. Pharmacogenom J 2005; 5(2): 102-11.
50. Albayrak A, Halici Z, Polat B, et al. Protective effects of lithium: A new look at an old drug with potential antioxidative and antiinflammatory effects in an animal model of sepsis. Int Immunopharmacol 2013; 16(1): 35-40.
51. Nciri R, Desmoulin F, Allagui MS, et al. Neuroprotective effects of chronic exposure of SH-SY5Y to low lithium concentration involve glycolysis stimulation, extracellular pyruvate accumulation and resistance to oxidative stress. Int J Neuropsychopharmacol 2013; 16(2): 365-76.
52. Jornada LK, Valvassori SS, Steckert AV, et al. Lithium and valproate modulate antioxidant enzymes and prevent ouabaininduced oxidative damage in an animal model of mania. J Psychiatr Res 2011; 45(2): 162-8.
53. Kim YH, Rane A, Lussier S, Andersen JK. Lithium protects against oxidative stress-mediated cell death in alpha-synucleinoverexpressing in vitro and in vivo models of Parkinson’s disease. J Neurosci Res 2011; 89(10): 1666-75.
54. Bengesser SA, Lackner N, Birner A, et al. Peripheral markers of oxidative stress and antioxidative defense in euthymia of bipolar disorder-Gender and obesity effects. J Affect Disord 2014; 172C: 367-74.
55. Delmotte P, Sieck GC. Interaction between endoplasmic/sarcoplasmic reticulum stress (ER/SR stress), mitochondrial signaling and Ca regulation in airway smooth muscle (ASM). Can J Physiol Pharmacol 2014; 25: 1-14.
56. Feng J, Chen X, Sun X, Wang F, Sun X. Expression of endoplasmic reticulum stress markers GRP78 and CHOP induced by oxidative stress in blue light-mediated damage of A2Econtaining retinal pigment epithelium cells. Ophthalmic Res 2014; 52(4): 224-33.
57. Lu TH, Su CC, Tang FC, et al. Chloroacetic acid triggers apoptosis in neuronal cells via a reactive oxygen species-induced endoplasmic reticulum stress signaling pathway. Chem Biol Interact 2015; 225: 1-12.
58. Kakiuchi C, Ishiwata M, Nanko S, et al. Functional polymorphisms of HSPA5: possible association with bipolar disorder. Biochem Biophys Res Commun 2005; 336(4): 1136-43.
59. Matigian N, Windus L, Smith H, et al. Expression profiling in monozygotic twins discordant for bipolar disorder reveals dysregulation of the WNT signalling pathway. Mol Psychiatry 2007; 12(9): 815-25.
60. So J, Warsh JJ, Li PP. Impaired endoplasmic reticulum stress response in B-lymphoblasts from patients with bipolar-I disorder. Biol Psychiatry 2007; 62(2): 141-7.
61. Sakurai K, Nishiguchi N, Shirakawa O, et al. Lack of association between endoplasmic reticulum stress response genes and suicidal victims. Kobe J Med Sci 2007; 53(4): 151-5.
62. Hayashi A, Kasahara T, Iwamoto K, et al. The role of brainderived neurotrophic factor (BDNF)-induced XBP1 splicing during brain development. J Biol Chem 2007; 282(47): 34525-34.
63. Kim B, Kim CY, Lee MJ, Joo YH. Preliminary evidence on the association between XBP1-116C/G polymorphism and response to prophylactic treatment with valproate in bipolar disorders. Psychiatry Res 2009; 168(3): 209-12.
64. Masui T, Hashimoto R, Kusumi I, et al. A possible association between the -116C/G single nucleotide polymorphism of the XBP1 gene and lithium prophylaxis in bipolar disorder. Int J Neuropsychopharmacol 2006; 9(1): 83-8.
65. Hou SJ, Yen FC, Cheng CY, Tsai SJ, Hong CJ. X-box binding protein 1 (XBP1) C--116G polymorphisms in bipolar disorders and age of onset. Neurosci Lett 2004; 367(2): 232-4.
66. Kakiuchi C, Ishiwata M, Hayashi A, Kato T. XBP1 induces WFS1 through an endoplasmic reticulum stress response element-like motif in SH-SY5Y cells. J Neurochem 2006; 97(2): 545-55.
67. Fonseca SG, Ishigaki S, Oslowski CM, et al. Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells. J Clin Invest 2010; 120(3): 744-55.
68. Yilmaz E, Akar R, Eker ST, Deda G, Adiguzel Y, Akar N. Relationship between functional promoter polymorphism in the XBP1 gene (-116C/G) and atherosclerosis, ischemic stroke and hyperhomocysteinemia. Mol Biol Rep 2010; 37(1): 269-72.
69. Kusumi I, Masui T, Kakiuchi C, et al. Relationship between XBP1 genotype and personality traits assessed by TCI and NEO-FFI. Neurosci Lett 2005; 391(1-2): 7-10.
70. Kato C, Kakiuchi C, Umekage T, et al. XBP1 gene polymorphism (-116C/G) and personality. Am J Med Genet B Neuropsychiatr Genet 2005; 136B(1): 103-5.
71. Watanabe Y, Fukui N, Muratake T, et al. Association study of a functional promoter polymorphism of the X-box binding protein 1 gene in Japanese patients with schizophrenia. Psychiatry Clin Neurosci 2006; 60(5): 633-5.
72. Jonsson EG, Cichon S, Schumacher J, et al. Association study of a functional promoter polymorphism in the XBP1 gene and schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2006; 141B(1): 71-5.
73. Morita Y, Ujike H, Tanaka Y, et al. The X-box binding protein 1 (XBP1) gene is not associated with methamphetamine dependence. Neurosci Lett 2005; 383(1-2): 194-8.
74. Kakiuchi C, Ishiwata M, Umekage T, et al. Association of the XBP1-116C/G polymorphism with schizophrenia in the Japanese population. Psychiatry Clin Neurosci 2004; 58(4): 438-40.
75. Aminzadeh A, Dehpour AR, Safa M, Mirzamohammadi S, Sharifi AM. Investigating the protective effect of lithium against high glucose-induced neurotoxicity in PC12 cells: involvements of ROS, JNK and P38 MAPKs, and apoptotic mitochondria pathway. Cell Mol Neurobiol 2014; 34(8): 1143-50.
76. Palsamy P, Bidasee KR, Shinohara T. Valproic acid suppresses Nrf2/Keap1 dependent antioxidant protection through induction of endoplasmic reticulum stress and Keap1 promoter DNA demethylation in human lens epithelial cells. Exp Eye Res 2014; 121: 26-34.
77. Carter CJ. eIF2B and oligodendrocyte survival: where nature and nurture meet in bipolar disorder and schizophrenia? Schizophr Bull 2007; 33(6): 1343-53.
78. Carter CJ. Multiple genes and factors associated with bipolar disorder converge on growth factor and stress activated kinase pathways controlling translation initiation: implications for oligodendrocyte viability. Neurochem Int 2007; 50(3): 461-90.
79. Huang S, Zhu M, Wu W, et al. Valproate pretreatment protects pancreatic beta-cells from palmitate-induced ER stress and apoptosis by inhibiting glycogen synthase kinase-3beta. J Biomed Sci 2014; 21: 38.
80. Kakiuchi C, Ishiwata M, Nanko S, et al. Association analysis of ATF4 and ATF5, genes for interacting-proteins of DISC1, in bipolar disorder. Neurosci Lett 2007; 417(3): 316-21.
81. Mamdani F, Alda M, Grof P, Young LT, Rouleau G, Turecki G. Lithium response and genetic variation in the CREB family of genes. Am J Med Genet B Neuropsychiatr Genet 2008; 147B(4): 500-4.
82. Teske BF, Fusakio ME, Zhou D, et al. CHOP induces activating transcription factor 5 (ATF5) to trigger apoptosis in response to perturbations in protein homeostasis. Mol Biol Cell 2013; 24(15): 2477-90.
83. Matsumoto H, Miyazaki S, Matsuyama S, et al. Selection of autophagy or apoptosis in cells exposed to ER-stress depends on ATF4 expression pattern with or without CHOP expression. Biol Open 2013; 2(10): 1084-90.
84. Zhang Z, Tong N, Gong Y, et al. Valproate protects the retina from endoplasmic reticulum stress-induced apoptosis after ischemiareperfusion injury. Neurosci Lett 2011; 504(2): 88-92.
85. Baysal BE, Willett-Brozick JE, Badner JA, et al. A mannosyltransferase gene at 11q23 is disrupted by a translocation breakpoint that co-segregates with bipolar affective disorder in a small family. Neurogenetics 2002; 4(1): 43-53.
86. Baysal BE, Willett-Brozick JE, Bacanu SA, Detera-Wadleigh S, Nimgaonkar VL. Common variations in ALG9 are not associated with bipolar I disorder: a family-based study. Behav Brain Funct 2006; 2: 25.
87. Chen DT, Jiang X, Akula N, et al. Genome-wide association study meta-analysis of European and Asian-ancestry samples identifies three novel loci associated with bipolar disorder. Mol Psychiatry 2013; 18(2): 195-205.
88. Lim CH, Zain SM, Reynolds GP, et al. Genetic association of LMAN2L gene in schizophrenia and bipolar disorder and its interaction with ANK3 gene polymorphism. Prog Neuropsychopharmacol Biol Psychiatry 2014; 54: 157-62.
89. Suzuki K, Kusumi I, Sasaki Y, Koyama T. Serotonin-induced platelet intracellular calcium mobilization in various psychiatric disorders: is it specific to bipolar disorder? J Affect Disord 2001; 64(2-3): 291-6.
90. Kusumi I, Suzuki K, Sasaki Y, Kameda K, Koyama T. Treatment response in depressed patients with enhanced Ca mobilization stimulated by serotonin. Neuropsychopharmacology 2000; 23(6): 690-6.
91. Akimoto T, Kusumi I, Suzuki K, Koyama T. Effects of calmodulin and protein kinase C modulators on transient Ca2+ increase and capacitative Ca2+ entry in human platelets: relevant to pathophysiology of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31(1): 136-41.
92. Akimoto T, Kusumi I, Suzuki K, Koyama T. Effects of calmodulin and protein kinase C modulators on transient Ca2+ increase and capacitative Ca2+ entry in human platelets: relevant to pathophysiology of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31(1): 136-41.
93. Mathieu F, Miot S, Etain B, et al. Association between the PPP3CC gene, coding for the calcineurin gamma catalytic subunit, and bipolar disorder. Behav Brain Funct 2008; 4: 2.
94. Beasley CL, Pennington K, Behan A, Wait R, Dunn MJ, Cotter D. Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes. Proteomics 2006; 6(11): 3414-25.
95. Psychiatric GWAS Consortium Bipolar Disorder Working Group. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 2011; 43(10): 977-83.
96. Petersen OH. Ca signalling in the endoplasmic reticulum/secretory granule microdomain. Cell Calcium 2015; 58(4): 397-404.
97. Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013; 381(9875): 1371-9.
98. Hamshere ML, Walters JT, Smith R, et al. Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Mol Psychiatry 2013; 18(6): 708-12.
99. Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 2011; 43(10): 969-76.
100. Clay HB, Sillivan S, Konradi C. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci 2011; 29(3): 311-24.
101. Kim JS, Heo RW, Kim H, Yi CO, Shin HJ, Han JW, Roh GS. Salubrinal, ER stress inhibitor, attenuates kainic acid-induced hippocampal cell death. J Neural Transm 2014; 121(10): 1233-43.
102. McIntyre RS, Woldeyohannes HO, Soczynska JK, et al. The rate of metabolic syndrome in euthymic Canadian individuals with bipolar I/II disorder. Adv Ther 2010; 27(11): 828-36.
103. Fu S, Yang L, Li P, et al. Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature 2011; 473(7348): 528-31.
104. Ghosh AK, Garg SK, Mau T, O’Brien M, Liu J, Yung R. Elevated Endoplasmic Reticulum Stress Response Contributes to Adipose Tissue Inflammation in Aging. J Gerontol A Biol Sci Med Sci 2015; 70(11): 1320-9.
105. Hakim F, Wang Y, Carreras A, et al. Chronic Sleep Fragmentation During the Sleep Period Induces Hypothalamic Endoplasmic Reticulum Stress and PTP1b-Mediated Leptin Resistance in Male Mice. Sleep 2015; 38(1): 31-40.
106. Khan S, Wang CH. ER stress in adipocytes and insulin resistance: mechanisms and significance. Mol Med Rep 2014; 10(5): 2234-40.
107. Nakagawa H, Umemura A, Taniguchi K, et al. ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development. Cancer Cell 2014; 26(3): 331-43.
108. Thon M, Hosoi T, Yoshii M, Ozawa K. Leptin induced GRP78 expression through the PI3K-mTOR pathway in neuronal cells. Sci Rep 2014; 4: 7096.
109. Novosyadlyy R, Kurshan N, Lann D, Vijayakumar A, Yakar S, LeRoith D. Insulin-like growth factor-I protects cells from ER stress-induced apoptosis via enhancement of the adaptive capacity of endoplasmic reticulum. Cell Death Differ 2008; 15(8): 1304-17.
110. Pereira AC, McQuillin A, Puri V, et al. Genetic association and sequencing of the insulin-like growth factor 1 gene in bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet 2011; 156(2): 177-87.
111. Yilmaz E, Berberoglu M, Akar N. Relationship between functional promoter polymorphism in the XBP1 gene (-116C/G) and obesity. Clin Appl Thromb Hemost 2010; 16(1): 99-102.
112. Bengesser SA, Lackner N, Birner A, et al. Peripheral markers of oxidative stress and antioxidative defense in euthymia of bipolar disorder - Gender and obesity effects. J Affect Disord 2014; 172C: 367-74.
113. Reininghaus EZ, Zelzer S, Reininghaus B, et al. Oxidative stress in bipolar affective disorder. Nervenarzt 2014; 85: 1099-1107.
114. Citrome L. Treatment of bipolar depression: making sensible decisions. CNS Spectr 2014; 19(Suppl 1): 4-11.
115. Kasper S, Kapfhammer HP, Bach M, et al. Bipolare Storungen. Konsensus-Statement _ State of the art 2013. CliniCum Neuropsy, Sonderausgabe, 2013.
116. Kurosawa S, Hashimoto E, Ukai W, Toki S, Saito S, Saito T. Olanzapine potentiates neuronal survival and neural stem cell differentiation: regulation of endoplasmic reticulum stress response proteins. J Neural Transm 2007; 114(9): 1121-8.